Capital Croissance

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Nov 9, 2009	Promethera Biosciences	$8.0M Series A	Vesalius Biocapital	Life Sciences Research Partners, LRM, Nivelinvest, Sopartec, SRIW, VIVES Louvain Technology Fund

Total Raised

N/A

Valuation

N/A

Key people at Capital Croissance.

Christophe Aulnette

Key people at Capital Croissance.

Christophe Aulnette